|
Danaher Inc
sox2 ![]() Sox2, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/mouse+monoclonal+Anti-SOX2+antibody/pmc04131214-132-41-47 Average 99 stars, based on 1 article reviews
sox2 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Addgene inc
sox2 expression vectors ![]() Sox2 Expression Vectors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/408+pSG5L+HA+E2F1+(Plasmid+%2310736)/pmc03427024-86-3-9 Average 93 stars, based on 1 article reviews
sox2 expression vectors - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
pmxs retroviral vectors expression mouse sox2 ![]() Pmxs Retroviral Vectors Expression Mouse Sox2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/pMXs-Sox2+(Plasmid+%2313367)/pm39043686-235-0-12 Average 93 stars, based on 1 article reviews
pmxs retroviral vectors expression mouse sox2 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Vigene Biosciences
recombinant adenovirus vectors expressing sox2 ![]() Recombinant Adenovirus Vectors Expressing Sox2, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/sox2+overexpression+or+control+plasmids/pmc07885160-88-0-24 Average 90 stars, based on 1 article reviews
recombinant adenovirus vectors expressing sox2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Addgene inc
sox2 ![]() Sox2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/FUW-tetO-hKLF4+(Plasmid+%2320725)/pm28962647-62-5-9 Average 93 stars, based on 1 article reviews
sox2 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
plko 1 sox2 3hm ![]() Plko 1 Sox2 3hm, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/pLKO%2E1+Sox2+HM+a+(Plasmid+%2326353)/pmc05570574-381-29-60 Average 92 stars, based on 1 article reviews
plko 1 sox2 3hm - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
New England Biolabs
pmd18t sox2 ![]() Pmd18t Sox2, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/BamHI/pmc07597407-27-9-19 Average 99 stars, based on 1 article reviews
pmd18t sox2 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Addgene inc
sox2 expression vector ![]() Sox2 Expression Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/pMSCV-Flag-hSox2+(Plasmid+%2320073)/pmc08028334-239-7-11 Average 93 stars, based on 1 article reviews
sox2 expression vector - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
lentiviral expression plasmid named psin ef2 puro ![]() Lentiviral Expression Plasmid Named Psin Ef2 Puro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/pSin-EF2-Sox2-Pur+(Plasmid+%2316577)/pm38849010-130-13-21 Average 93 stars, based on 1 article reviews
lentiviral expression plasmid named psin ef2 puro - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
pcx oks 2a ![]() Pcx Oks 2a, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/pCX-OKS-2A+(Plasmid+%2319771)/pmc03458059-145-1-20 Average 93 stars, based on 1 article reviews
pcx oks 2a - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Proteintech
sox2 ![]() Sox2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/SOX2+Antibody/10__1074_slash_jbc__c114__561860-48-18-17 Average 96 stars, based on 1 article reviews
sox2 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Genecopoeia
human immortalized myoblasts ![]() Human Immortalized Myoblasts, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sox2+expression+vector/Promoter+reporter+clone+for+Human+SOX2/pmc04939618-404-5-14 Average 94 stars, based on 1 article reviews
human immortalized myoblasts - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Scientific Reports
Article Title: The newt reprograms mature RPE cells into a unique multipotent state for retinal regeneration
doi: 10.1038/srep06043
Figure Lengend Snippet: (a–d), Single-cell qPCR. Normal RPE cells (day 0) and RPE-derived cells (day 10) were isolated from the control and retinectomised eyes of the same animal at day 10 after retinectomy (a). In each-day sample, RPE cells were identified by their morphological characteristics (cells with a pigmented apical part and a non-pigmented part with the nucleus), and solitary cells were manually selected under a dissecting microscope. First, 100 cells on days 0 and 10 were harvested into different tubes to prepare each cDNA sample, and real-time PCR was carried out using these samples for RPE65 , c-Myc , Klf4 , Sox2 , Mitf , Pax6 and Ef1α . A comparison of the expression levels of genes that compensated for Ef1α is shown in b. Numbers in parentheses represent the ratio of detection (dominator: sample number). The same experiments were performed with one-cell samples. The cumulative detection rates of genes in RPE65 + cells are shown in c. Raw data tables mentioning the Cq values are shown in d. Horizontal bars indicate no detection. e, Sox2 immunohistochemistry in Stage E-0 to E-2 regenerating retinas. Tissues were bleached. Sox2-IR was first detected in a small number of RPE-derived cells at stage E-1 (arrowhead) and then along the inner rudimentary layer (pro-NR layer) at stage E-2. Green horizontal lines in stage E-2: borders of the pro-NR and pro-RPE layers. Scale bars: 50 μm for a and e. f, Summary of the current results and proposed mechanism.
Article Snippet: The primary and secondary antibodies used for immunoblotting and immunohistochemistry were as follows: for Pax6, mouse monoclonal anti-Pax6 antibody (1:100; AD2.38, sc-32766; Santa Cruz Biotechnology, TX 75220, U.S.A) and biotinylated goat anti-mouse IgG antibody (1:500; Vector Laboratories, CA 94010, U.S.A); for
Techniques: Derivative Assay, Isolation, Microscopy, Real-time Polymerase Chain Reaction, Expressing, Immunohistochemistry
Journal: Oncology Letters
Article Title: SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3β signaling pathway in esophageal squamous cell carcinoma
doi: 10.3892/ol.2021.12530
Figure Lengend Snippet: Activation of AKT by adenoviral vector-mediated overexpression of SOX2. (A) KYSE30 and TE4 cells, which are known to express SOX2 at low levels, were infected with Ad-SOX2 or Ad-control. Cells were harvested 48 h after infection and subjected to immunoblot analysis of SOX2, p-AKT (S473), total AKT, p-ERK and total ERK expression. (B) Time course of changes in the levels of SOX2, p-AKT (T308), p-AKT (S473) and total AKT. TE4 cells were infected with Ad-SOX2 and harvested at the indicated time points after infection, then subjected to immunoblot analysis. (C) Effect of MK2206. TE6 cells, which express a high endogenous level of SOX2, were treated for 48 h with MK2206, an AKT inhibitor, at the indicated concentrations for 48 h, then subjected to immunoblot analysis of SOX2, p-AKT (S473) and total AKT levels. (D) TE6 cells were treated with 2 µM MK2206 for different time periods and harvested at the indicated time points, then subjected to immunoblot analysis of SOX2, p-AKT (S473) and total AKT expression. For all experiments, β-actin was detected as a loading control. The numbers presented below the gels represent the expression levels of each protein relative to those of β-actin. Values were normalized so that β-actin expression in each well had a value of 1. The ratio of p-AKT (S473 or T308) to total AKT is shown. Ad, adenovirus vector; p-, phosphorylated.
Article Snippet:
Techniques: Activation Assay, Plasmid Preparation, Over Expression, Infection, Control, Western Blot, Expressing
Journal: Oncology Letters
Article Title: SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3β signaling pathway in esophageal squamous cell carcinoma
doi: 10.3892/ol.2021.12530
Figure Lengend Snippet: Activation of AKT by SOX2 under serum starvation conditions. (A) KYSE30 cells were infected with Ad-SOX2 or Ad-control. After a 24-h incubation, cells were cultured in serum-free medium for 24 h. Subsequently, cells were incubated in growth medium without or with serum (10%) for 15 min (− serum or + serum, respectively), harvested and subjected to immunoblot analysis of SOX2, p-AKT (S473) and total AKT expression. (B) KYSE140 cells were transfected with one of two siRNAs targeting SOX2 (SOX2 siRNA #1 and #2) or with a control siRNA. After a 48-h incubation, cells were cultured in serum-free medium for 12 h. Subsequently, cells were incubated in growth medium without or with serum (10%) for 15 min (− serum or + serum, respectively), harvested and subjected to immunoblot analysis of SOX2, p-AKT (S473) and total AKT expression. For all experiments, β-actin was detected as a loading control. The numbers presented below the gels represent the expression levels of each protein relative to those of β-actin. Values were normalized so that β-actin expression in each well had a value of 1. The ratio of p-AKT (S473) to total AKT is shown. Ad, adenovirus vector; p-, phosphorylated; siRNA, small interfering RNA.
Article Snippet:
Techniques: Activation Assay, Infection, Control, Incubation, Cell Culture, Western Blot, Expressing, Transfection, Plasmid Preparation, Small Interfering RNA
Journal: Oncology Letters
Article Title: SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3β signaling pathway in esophageal squamous cell carcinoma
doi: 10.3892/ol.2021.12530
Figure Lengend Snippet: Promotion of cell survival under serum starvation conditions and resistance to apoptosis through activation of the AKT/GSK-3β signaling pathway by SOX2. (A) TE4 cells were infected with Ad-SOX2 or Ad-control, and then cultured in serum-free medium (− serum) or medium with serum (+ serum). Relative cell viabilities were measured at the indicated time points. (B) TE4 cells were infected with Ad-SOX2 or Ad-control, then treated 24 h later with the indicated concentrations of MK2206 in serum-free medium. Cell viabilities were measured 48 h after MK2206 treatment. (C) TE4 cells were infected with Ad-SOX2 or Ad-control, then treated 24 h later with the indicated concentrations of doxorubicin in serum-free medium. Cell viabilities were measured 48 h after doxorubicin treatment. (D) TE4 cells were infected with Ad-SOX2 or Ad-control, then treated 24 h later with 3 µM doxorubicin and 2 µM MK2206 in serum-free medium. After a 48-h incubation, cells were subjected to cell viability assays. (E) TE4 cells were infected with Ad-SOX2 or Ad-control, then treated 24 h later with or without 3 µM doxorubicin in serum-free medium. Cells were harvested 48 h after doxorubicin treatment and subjected to immunoblot analysis of PARP, cleaved PARP, p-GSK-3β and total GSK-3β expression. β-actin was detected as a loading control. The numbers presented above and below the gel for PARP and cleaved PARP represent the expression levels of PARP and cleaved PARP relative to those of β-actin, respectively. The numbers presented below the gels for p-GSK-3β and total GSK-3β represent the expression levels of p-GSK-3β and total GSK-3β relative to those of β-actin, respectively. Values were normalized so that β-actin expression in each well had a value of 1. The ratio of p-GSK-3β to total GSK-3β is shown. (F) TE4 cells were infected with Ad-SOX2, and treated 24 h later with AR-A014418 or DMSO. The cells were treated 24 h later with or without 3 µM doxorubicin in serum-free medium. Cell viability was measured 72 h after doxorubicin treatment. All data are presented as the mean ± SD (n=3). *P<0.01 analyzed by two-tailed unpaired Student's t-test. OD, optical density; Ad, adenovirus vector; p-, phosphorylated; GSK-3β, glycogen synthase kinase-3β; PARP, poly (ADP-ribose) polymerase.
Article Snippet:
Techniques: Activation Assay, Infection, Control, Cell Culture, Incubation, Western Blot, Expressing, Two Tailed Test, Plasmid Preparation
Journal: Oncology Letters
Article Title: SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3β signaling pathway in esophageal squamous cell carcinoma
doi: 10.3892/ol.2021.12530
Figure Lengend Snippet: PTEN/PI3K/PDK1- and mTORC2-mediated phosphorylation of AKT in SOX2-overexpressing cells. (A) KYSE140 and TE6 cells were treated with the indicated concentrations of LY294002, a PI3K inhibitor, in serum-free medium for 48 h, harvested and subjected to immunoblot analysis of SOX2, p-AKT (S473) and total AKT expression. (B) KYSE70, KYSE140 and TE6 cells were transfected with either SOX2 siRNA#1 or with a control siRNA. After a 48-h incubation in serum-free medium, cells were harvested and subjected to immunoblot analysis of SOX2, PTEN, p-AKT (S473) and total AKT expression. TE4 cells infected with Ad-SOX2 and KYSE140 cells were treated for 1 h in serum-free medium containing the indicated concentrations of (C) GSK2334470, a PDK1 inhibitor, or (D) AZD8055, an mTORC2 inhibitor. Cells were harvested and subjected to immunoblot analysis of SOX2, p-AKT (T308 or S473) and total AKT expression. For all experiments, β-actin was detected as a loading control. The numbers presented below the gels represent the expression levels of each protein relative to those of β-actin. Values were normalized so that β-actin expression in each well had a value of 1. The ratio of p-AKT (S473 or T308) to total AKT is shown. PI3K, phosphatidylinositol 3-kinase; Ad, adenovirus vector; p-, phosphorylated; siRNA, small interfering RNA; PDK1, phosphoinositide-dependent protein kinase 1; mTORC2, mammalian target of rapamycin complex 2.
Article Snippet:
Techniques: Phospho-proteomics, Western Blot, Expressing, Transfection, Control, Incubation, Infection, Plasmid Preparation, Small Interfering RNA
Journal: eLife
Article Title: NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
doi: 10.7554/eLife.26733
Figure Lengend Snippet: ( A–D ) Pluripotency genes expressions analyzed by qPCR in HCC827 ( A ), PDCL#24 ( B ), A549 ( C ), and H1299 cells ( D ) with NFATc2 knockdown or overexpression. ( E ) Effects of stable NFATc2 knock-down, knockout or overexpression on SOX2 expression in respective lung cancer cells by Western blot analysis. ( F–G ) Pluripotency genes expression analyzed by qPCR in HCC827 ( F ), and PDCL#24 cells ( G ) treated with CSA or FK506, respectively, for 24 hr. ( H–I ) Effects of transient knockdown of PPP3R1 on pluripotency gene expressions analyzed by qPCR in HCC827 ( H ) and PDCL#24 cells ( I ). ( J–K ) Effects of transient knockdown of NFATc1 on pluripotency gene expressions analyzed by qPCR in HCC827 ( J ) and PDCL#24 cells ( K ). *p<0.05, **p<0.01 versus control by t-test. Error bar indicates the mean ±S.D. for at least three independent replicates. DOI: http://dx.doi.org/10.7554/eLife.26733.017
Article Snippet: Small interfering RNA (siRNA) with pre-designed sequences targeting human NFATc1, PPP3R1, ALDH1A1 and scramble siRNA were from Sigma-Aldrich (St Louis, MO). pGL3-NFAT luciferase (17870), two shRNA sequences targeting SOX2,
Techniques: Knockdown, Over Expression, Knock-Out, Expressing, Western Blot, Control
Journal: eLife
Article Title: NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
doi: 10.7554/eLife.26733
Figure Lengend Snippet: ( A ) Computational prediction of NFAT binding sites (marked in red) on 5’ and 3’ SOX2 regulatory regions (Region 1 to 4). TSS: transcription start site. ( B ) Transcriptional activities of the respective SOX2 regions 1–4 of H441 cells analyzed by luciferase reporter assays. *p<0.05, **p<0.01 versus control by Student’s t-test. Error bars indicate the mean ±SD for at least three independent replicates. ( C–D ) Luciferase reporter activities of mutant or wild-type SOX2 reporters of A549 ( C ), or H1299 cells ( D ), with or without NFATc2 stable overexpression. *p<0.05, **p<0.01, comparison with RFP; # p<0.05, ## p<0.01, wild type versus mutant in RFP-NFATc2 cells by t-test. Error bars indicate the mean ±SD for at least three independent replicates. DOI: http://dx.doi.org/10.7554/eLife.26733.021
Article Snippet: Small interfering RNA (siRNA) with pre-designed sequences targeting human NFATc1, PPP3R1, ALDH1A1 and scramble siRNA were from Sigma-Aldrich (St Louis, MO). pGL3-NFAT luciferase (17870), two shRNA sequences targeting SOX2,
Techniques: Binding Assay, Luciferase, Control, Mutagenesis, Over Expression, Comparison
Journal: eLife
Article Title: NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
doi: 10.7554/eLife.26733
Figure Lengend Snippet: ( A ) Genome browser view of NFAT binding sites and H3K27Ac marks (lowest panel) on SOX2 regulatory regions (regions 2 and 3 indicated in ) analyzed in A549 cells. ( B ) Transcriptional activities of sites 1–5 by dual luciferase reporter assays in H441 cells. ( C ) Transcriptional activities of the indicated putative NFAT binding sites by respective luciferase reporters in H441 cells with transient NFATc2 over-expression, with or without CSA treatment. ( D ) Effects of site-directed mutagenesis of the indicated putative NFAT binding sequences by respective luciferase reporter assays in H441 cells with transient NFATc2 overexpression. For B-D, *p<0.05, **p<0.01 versus control by t-test. Error bar indicates the mean ±S.D. for at least three independent replicates. ( E ) Alignment of sites 4 and 5 genomic sequences showing highly homologous regions (gray) in different mammalian species, with putative NFAT binding sites highlighted in red. ( F–G ) ChIP–qPCR assays of NFATc2 binding to the indicated SOX2 sites in A549 cells with or without stable NFATc2 overexpression ( F ), or HCC827 cells with or without NFATc2 knockout ( G ). # p<0.05, ## p<0.01 versus IgG control,m **p<0.01 versus vector control by t-test. Error bar indicates the mean ±S.D. for at least three independent replicates. ( H ) Correlation of immunohistochemical expressions of NFATc2 and SOX2 in 92 moderately to poorly differentiated human lung adenocarcinoma by χ 2 -test. Pearson R, Pearson correlation coefficient. ( I ) Correlation of mRNA levels of SOX2 and NFATc2 in a panel of lung AD cell lines analyzed by q-PCR and Pearson correlation test. ( J ) Expression of NFATc2 and SOX2 in A549 cells with or without NFATc2 overexpression and SOX2 stable knockdown by Western blot. ( K–L ) Effect of SOX2 knockdown on tumorsphere formation ( K ), cell migration and invasion ability ( L ), of A549 cells with NFATc2 overexpression. *p<0.05, **p<0.01 versus control by t-test. Error bars indicate the mean ±SD for at least three independent replicates. ( M ) In vivo tumorigenicity of A549 cells with NFATc2 overexpression and SOX2 knockdown by subcutaneous inoculation of 1 × 10 4 cells in SCID mice. **p<0. 0001 versus control by two-way ANOVA. Error bar indicates the mean ±SD of tumor volumes of six mice. ( N ) Effect of NFATc2 knockdown on SOX2 expression in A549 CR cells analyzed by immunoblot. ( L ) Effect of SOX2 knockdown on cisplatin sensitivity by MTT assay of A549 cells with NFATc2 overexpression. ## p<0.01, versus vector control, **p<0.01 versus RFP-NFATc2_Sh-Ctrl by t-test. Error bar indicates the mean ±SD for at least three independent replicates. DOI: http://dx.doi.org/10.7554/eLife.26733.019 10.7554/eLife.26733.020 Figure 6—source data 1. Statistical analyses for . DOI: http://dx.doi.org/10.7554/eLife.26733.020
Article Snippet: Small interfering RNA (siRNA) with pre-designed sequences targeting human NFATc1, PPP3R1, ALDH1A1 and scramble siRNA were from Sigma-Aldrich (St Louis, MO). pGL3-NFAT luciferase (17870), two shRNA sequences targeting SOX2,
Techniques: Binding Assay, Luciferase, Over Expression, Mutagenesis, Control, Genomic Sequencing, ChIP-qPCR, Knock-Out, Plasmid Preparation, Immunohistochemical staining, Expressing, Knockdown, Western Blot, Migration, In Vivo, MTT Assay
Journal: eLife
Article Title: NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
doi: 10.7554/eLife.26733
Figure Lengend Snippet: ( A–D ) Effects on ALDH + , CD44 + and ALDH + /CD44 + cell populations by flow cytometry analysis of HCC827 with NFATc2 knockdown ( A ), NFATc2 knockout ( B ), or NFATc2 inhibition by CSA or FK506 ( C ), and of A549 cells with NFATc2 overexpression ( D ). ( E–H ) Effects on ALDH1A1 mRNA expression by qPCR analysis of cancer cells with NFATc2 knockdown ( E ), NFATc2 inhibition by CSA or FK506 ( F ), NFATc2 up-regulation ( G ), or of A549 with induced cisplatin resistance ( H ). ( I ) Effects of SOX2 knockdown on ALDH + , CD44 + and ALDH + /CD44 + cell populations by flow cytometry in A549 with NFATc2-overexpression. ( J ) Expression of SOX2 and ALDH1A1 transcripts in A549 cells with NFATc2 overexpression and SOX2 knockdown. ( K ) Representative images of A549 xenografts with or without NFATc2 overexpression immunohistochemically stained for NFATc2, SOX2 and ALDH1A1, respectively. Scale bars, 50 µm. ( L ) Conserved SOX2 binding sequences (ATTCA) at ALDH1A1 enhancer region by ChIP-seq of PDCL#24 cells, aligned with homologous mammalian sequences and H3K27Ac peaks of A549 cells from published databases. ( M ) Detection of endogenous SOX2 binding to ALDH1A1 sites by ChIP–qPCR analysis in PDCL#24 cells. ( N ) Luciferase reporter activities at sites 1 and 2 of ALDH1A enhancer region by dual luciferase reporter assay in A549 cells with SOX2 overexpression. ( O–P ) Effects of transient ALDH1A1 suppression on A549 with upregulated NFATc2 with respect to invasion and migration ( O ), and cisplatin sensitivity. ## p<0.01, versus RFP_Scramble by t-test. ( P ). ( Q ) Correlation between ALDH1A1 and SOX2 expressions by IHC in human lung adenocarcinomas by χ 2 -test. *p<0.05, **p<0.01 versus control by t-test. Error bar indicates the mean ±S.D. for at least three independent replicates. DOI: http://dx.doi.org/10.7554/eLife.26733.022 10.7554/eLife.26733.023 Figure 7—source data 1. Statistical analyses for . DOI: http://dx.doi.org/10.7554/eLife.26733.023
Article Snippet: Small interfering RNA (siRNA) with pre-designed sequences targeting human NFATc1, PPP3R1, ALDH1A1 and scramble siRNA were from Sigma-Aldrich (St Louis, MO). pGL3-NFAT luciferase (17870), two shRNA sequences targeting SOX2,
Techniques: Flow Cytometry, Knockdown, Knock-Out, Inhibition, Over Expression, Expressing, Staining, Binding Assay, ChIP-sequencing, ChIP-qPCR, Luciferase, Reporter Assay, Migration, Control
Journal: eLife
Article Title: NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
doi: 10.7554/eLife.26733
Figure Lengend Snippet: ( A ) ROS levels detected by flow cytometry in A549 and A549 CR cells. ( B–C ) ROS levels in HCC827 cells ( B ) and PDCL#24 cells ( C ) with or without NFATc2 stable knockdown. ( D ) ROS levels in HCC827 cells with or without NFATc2 knockout. ( E–F ) Cisplatin sensitivity expressed as IC 50 by MTT assays of NFATc2-silenced PDCL#24 cells treated with increasing doses of NAC ( E ), or NFATc2-overexpressing A549 cells treated with the oxidizing agent BSO ( F ), respectively. *p<0.05, **p<0.01 versus vector control without REDOX reagents; ## p<0.01 versus the corresponding treatment control by t-tests. Error bar indicates the mean ±S.D. for three independent replicates. ( G–H ) Effects of increasing doses of NAC on tumorsphere formation ability of HCC827 ( G ) cells and PDCL#24 cells ( H ). *p<0.05, **p<0.01 versus corresponding treatment controls, ## p<0.01 versus vector control by t-test. Error bar indicates the mean ±S.D. for three independent replicates. ( I ) Effects of increasing doses of NAC on cell migration and invasion of HCC827 cells with NFATc2 down-regulation by 2 sh-RNA knockdown sequences. ( J–K ) ROS levels in NFATc2-overexpressing A549 cells with stable SOX2 ( J ) or transient ALDH1A1 ( K ) knockdown. *p<0.05, **p<0.01 versus respective control by t-test. Error bar indicates the mean ±S.D. for at least three independent replicates. DOI: http://dx.doi.org/10.7554/eLife.26733.028 10.7554/eLife.26733.029 Figure 8—source data 1. Statistical analyses for . DOI: http://dx.doi.org/10.7554/eLife.26733.029
Article Snippet: Small interfering RNA (siRNA) with pre-designed sequences targeting human NFATc1, PPP3R1, ALDH1A1 and scramble siRNA were from Sigma-Aldrich (St Louis, MO). pGL3-NFAT luciferase (17870), two shRNA sequences targeting SOX2,
Techniques: Flow Cytometry, Knockdown, Knock-Out, Plasmid Preparation, Control, Migration
Journal: eLife
Article Title: NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
doi: 10.7554/eLife.26733
Figure Lengend Snippet: Expressions of total β-catenin, active β-catenin (non-phosphorylated), and phosphorylated β-catenin (p-β-catenin) analyzed by immunoblot in A549 with or without NFATc2 overexpression and SOX2 knockdown. DOI: http://dx.doi.org/10.7554/eLife.26733.027
Article Snippet: Small interfering RNA (siRNA) with pre-designed sequences targeting human NFATc1, PPP3R1, ALDH1A1 and scramble siRNA were from Sigma-Aldrich (St Louis, MO). pGL3-NFAT luciferase (17870), two shRNA sequences targeting SOX2,
Techniques: Western Blot, Over Expression, Knockdown
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: (A) Chicken Sox2 cDNA was cloned using RT-PCR. Lane M: DL 2000 DNA marker; lane 1: Sox2 cDNA PCR product (approximately 1 kb); lane 2: negative control (water was used as template). (B) Construction of cloning vector by TA cloning. Lane M: DL 2000 DNA marker; lane 1-2: pMD18-T- Sox2 digested by Bam HⅠ and Xho Ⅰ.
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: Clone Assay, Reverse Transcription Polymerase Chain Reaction, Marker, Negative Control, Cloning, Plasmid Preparation, TA Cloning
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: Construction of prokaryotic expression vector. Lane M 1 : DL 10,000 DNA marker; lane 1: pET- Sox2 digested by Bam HⅠ and Xho Ⅰ; lane M 2 : DL 2000 DNA marker.
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: Expressing, Plasmid Preparation, Marker
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: (A) SDS-PAGE profile of cell lysate from pET- Sox2 -transformed E. coli BL21 cells. Lane M: molecular weight markers; lane 1: not induced; lane 2: induced with 1 mmol IPTG. (B) SDS-PAGE profile of His-Sox2 protein fractions isolated from E. coli BL21 cell lysate. Lane M: prestained protein marker; lane 1-2: buffer E elution of His-Sox2 fusion protein. (C) Western blotting assay for the expression of the His-Sox2 fusion protein. The purified His-Sox2 protein could specifically bind to both monoclonal anti-His and antichicken Sox2 antibodies, whereas the controls could not (lane 1 and 2). Lane M: prestained protein marker; lane 1: intact E. coli BL21 cell lysate; lane 2: the cell lysate of recombinant E. coli BL21 without induction of IPTG; lanes 3–6: elution fractions of the His-Sox2 protein.
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: SDS Page, Transformation Assay, Molecular Weight, Isolation, Marker, Western Blot, Expressing, Purification, Recombinant
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: Western blotting assay for specificity of the antichicken Sox2 polyclonal antibody. The antichicken polyclonal Sox2 antibody could specifically bind to the intrinsic Sox2 protein from the testes, but almost no immunoblotting bands were detected in the myocardium (A); relative Sox2 expression was quantified by densitometric scanning of 3 independent immunoblots. Sox2 expression levels were significantly higher in the testes than in myocardium (B). ** P < 0.001. The immunoreactivity to antichicken Sox2 depended on the amount of Sox2 protein from the testes, that is, the higher the amount of Sox2 protein, the stronger the displayed immunoreactivity (C). β-actin was used as an internal control. The rabbit preimmune serum and commercial antimouse Sox2 antibody were used as negative and positive primary antibody controls, respectively.
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: Western Blot, Expressing, Control
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: IHC staining of the endogenous Sox2 protein in the testes and myocardium of a newly hatched rooster. Cryosections (6 μm) of OCT-embedded tissue stained with the primary antibody (antichicken/mouse Sox2 polyclonal antibody), biotin-conjugated goat antirabbit-IgG, and HRP-conjugated streptavidin. (A, E) HE staining of testis and myocardium tissues used for routine control visualization of microstructure. (B, F) Negative controls for testis and myocardium tissues. (C, D) Sox2 IHC staining in testes. Most spermatogonia of seminiferous tubules (black arrows), and a small number of Sertoli cells and Leydig cells (green arrows), were positive for Sox2. ST, seminiferous tubules; TIC, testis interstitial cells. (G, H) Sox2 IHC staining in myocardium. No Sox2 immunoreactivity was detected in myocardium.
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: Immunohistochemistry, Staining, Control
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: Sox2 overexpression and indirect immunofluorescence staining assay. Sox2-overexpressing BRL cells were labelled with the primary antibody (antichicken/antimouse Sox2 polyclonal antibody), detected with FITC-conjugated goat antirabbit-IgG, and subsequently counterstained with DAPI. Strong nuclear and diffuse cytoplasmic immunoreactivity for Sox2 was detected both in the anti-chicken Sox2 antibody (A) and in the commercial Sox2 antibody (E) staining cells, but not in the negative-control cells (I) (omitting the primary antibody), and in pre-immune serum staining cells (M). Sox2-overexpressing BRL cells counterstained with DAPI (B, F, J, N); Sox2-overexpressing BRL cells in bright field (C, G, K, O); merged microphotographs of the left three corresponding panels (D, H, L, P).
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: Over Expression, Immunofluorescence, Staining, Negative Control
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: CRISPR/Cas9 effector system–mediated Sox2 knockdown assay. In the presence or absence of doxycycline, HEK 293T cells were infected with combination of 3 lentiviral plasmids, plenti6.4- Sox2 , pHAGETRE-dCas9, or pHAGE TRE-dCas9-KRAB and pLenti Sp Bsm BI Sox2 sgRNA Puro, and whole cell lysates were prepared from the cells 72 h after transduction and subjected to immunoblot analysis with the antichicken Sox2 antibody and the anti-ß-actin antibody (internal control). In the presence of doxycycline, the TRE promoter induced the expression of dCas9 or dCas9-KRAB and Sox2 expression decreased; in contrast, in the absence of doxycycline, Sox2 expression increased (A). Relative Sox2 expression was quantified by densitometric scanning of independent immunoblots 3 times (B). The depression efficiency of dCas9-KRAB for Sox2 expression was significantly higher than that of dCas9 alone (B). ∗∗ P < 0.001.
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: CRISPR, Knockdown, Infection, Transduction, Western Blot, Control, Expressing
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: Further application of antichicken Sox2 antibody in detecting Sox2 distribution and expression in chicken cerebellar cortex, the tectum of midbrain, cerebral cortex, and lung tissues. (A–D) HE staining of cerebellar cortex, the tectum of midbrain, cerebral cortex and lung tissues. PM: Pia mater, IGL: Internal granule cell layer (A); SO: stratum opticum (B); EPL: external pyramidal layer, IPL: internal pyramidal layer (C); TB: tertiary bronchus, RC: respiratory capillary, A: atrium (D). (E–H) Negative controls for the above 4 different tissues. (I, M) Sox2 IHC staining in cerebellar cortex. Immunoreactivity for Sox2 was detected in external granular layer (EGL) (black arrows), Purkinje cell layer (PCL) (green arrows), and scattered immune-positive cells both in white matter (WM) (red arrows) and molecular layer (ML) (blue arrows). (J, N) Sox2 IHC staining in the optic tectum of midbrain. Sox2-positive cells were distributed in the stratum griseum et fibrosum suprerficiale (SGFS), stratum griseum centrale (SGC), stratum album centrale (SAC), stratum griseum periventricular (SGP), and neuronal cell layers (black arrows) on the edge of midbrain ventricle (MV). (K, O) Sox2 IHC staining in cerebral cortex. Majority of neurons in polymorphic layer (PL) were strongly positive for Sox2. (L, P) Sox2 IHC staining in lungs. Strong immunoreactivity was detected in mucosal epithelium (ME) of secondary bronchus (SB) (black arrows), but scattered glands in submucosa (GIS) were weakly positive for Sox2 (red arrows).
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: Expressing, Staining, Immunohistochemistry
Journal: Poultry Science
Article Title: Specificity and application of SOX2 antibody
doi: 10.1016/j.psj.2020.01.001
Figure Lengend Snippet: Western blotting assay for Sox2 expression in brain and lungs. The anti-chicken Sox2 polyclonal antibody was used as the primary antibody and HRP-conjugated goat anti-rabbit IgG as secondary antibody. Beta-actin was used as an internal control. Sox2 protein extracted from the brain and lungs of a newly hatched rooster was used as the antigen. Immunoblotting bands were detected both in brain and lungs (A). The relative Sox2 expression was quantified by densitometric scanning of 3 independent immunoblots (B). The relative Sox2 expression levels were higher in brain than in lungs. ∗∗ P < 0.001.
Article Snippet: After DNA sequence analysis and online signal peptide prediction,
Techniques: Western Blot, Expressing, Control
Journal: Brain Pathology
Article Title: Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1
doi: 10.1111/bpa.12670
Figure Lengend Snippet: 3q26 genes SOX2 and OPA1 are targeted in glioma. A. Schematic illustration of chromosome segment 3q26 with indication of relative position and orientation of PIK3CA, MFN1, SOX2 and OPA1 genes. B. Frequency of genomic amplification (red) and deletion (blue) of 3q26 genes as determined by quantitative PCR of DNA from 129 glioma biopsies. C. Protein levels of SOX2 and OPA1 determined by mass spectrometry in six representative glioma biopsies (T) compared with corresponding non‐tumorous white matter (N). The glioma biopsies were genotyped to be either IDH wild type or mutant, or carrying SOX2 amplification (SOX2 > 2n) or OPA1 deletion (OPA1 < 2n). “Others” stands for glioma with neither SOX2 amplification nor OPA1 deletion.
Article Snippet: SOX2 was overexpressed by addition of an
Techniques: Amplification, Real-time Polymerase Chain Reaction, Mass Spectrometry, Mutagenesis
Journal: Brain Pathology
Article Title: Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1
doi: 10.1111/bpa.12670
Figure Lengend Snippet: SOX2 amplification and OPA1 deletion are associated with larger necrotic volumes in the glioma mass. A. Neuroimaging (left) and color modelization (right) of the tumor compartments of the same glioma. B. Neuroimaging of representative glioma cases with neither SOX2 amplification nor OPA1 deletion (left) with SOX2 amplification (center) and OPA1 deletion (right). C. Boxplots visualizing the distribution of the log‐transformed volume of necrotic compartment of gliomas across different statuses of SOX2 and OPA1. The boxes display the median and the interquartile range. Coefficients estimates for a linear model with log‐transformed necrosis volume and adjusted for age and ratio of postoperative to preoperative volume are shown below the boxplots. D. Comparative invasion kinetics of LN319 cells in the presence of autologous necrotic LN319 cells. Parental LN319 (left), LN319 overexpressing cherry‐SOX2 under the control of 30 ng/ml doxycycline (middle) and L319 with OPA1 knocked down by shRNA (right). Invasiveness in absence of necrotic cells was set to 100% (reference score). Significance cutoff: *P < 0.05.
Article Snippet: SOX2 was overexpressed by addition of an
Techniques: Amplification, Transformation Assay, shRNA
Journal: Brain Pathology
Article Title: Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1
doi: 10.1111/bpa.12670
Figure Lengend Snippet: SOX2 and OPA1 modulate glioma cell invasion in vitro and in vivo. A. Inducible SOX2 overexpression in LN319 cells. LN319 stably transfected with an mCherry‐SOX2 fusion construct under control of a doxycycline‐inducible promoter. Western blot documenting dose‐dependent induction of the fusion protein (anti‐SOX2 staining, two exposure times, left). Fluorescence microscopy verifying effective nuclear localization of mCherry‐SOX2 24 h past induction (middle). SOX2‐dependent modulation of cell invasiveness as investigated by 24 h Boyden chamber assay (right). B. shRNA‐driven OPA1 knock‐down in LN319 cells. Western blot of transfected LN319 cells (left). Verification of knock‐down phenotype by mitochondria morphology in transfected LN319 (middle). Comparative cell invasion in response by 24 h Boyden chamber assay (right).
Article Snippet: SOX2 was overexpressed by addition of an
Techniques: In Vitro, In Vivo, Over Expression, Stable Transfection, Transfection, Construct, Western Blot, Staining, Fluorescence, Microscopy, Boyden Chamber Assay, shRNA
Journal: Brain Pathology
Article Title: Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1
doi: 10.1111/bpa.12670
Figure Lengend Snippet: A. OPA1 knock‐down increases invasiveness of LN319 cells in vivo. Left: Confocal pictures of zebrafish embryos effectively xenotransplanted with LN319 control cells (shRNA non‐coding, left) or LN319 shOPA1 knock‐down cells (right). LN319 cells (Cell Tracker, red) either established stable cell masses near the site of injection (aggregate growth, top), dispersed throughout the yolk sack (invasive growth, center) or disseminated to the caudal hematopoietic tissue (CHT) of the tail fin (bottom). Inlays indicate absolute animal numbers per condition. Right: Relative quantification of experimental outcomes documenting aggravated invasiveness and dissemination of OPA1 knock‐down vs. respective control cells. B. SOX2 overexpression (OE) increases invasiveness of LN319 cells in vivo. Experimental setup as above, except that TetON (control, left) and TetON mCherry‐SOX2 (SOX2 OE, right) cells had been pretreated with doxycycline (1 µg/ml for 24 h) to selectively induce SOX2 protein formation prior to transplantation. Right: Assay quantification verifying increased invasiveness and dissemination to CHT (by trend) also for SOX2 OE cells when compared to equally treated controls. Significance cut‐off‐: *P < 0.05.
Article Snippet: SOX2 was overexpressed by addition of an
Techniques: In Vivo, shRNA, Stable Transfection, Injection, Over Expression, Transplantation Assay
Journal: Brain Pathology
Article Title: Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1
doi: 10.1111/bpa.12670
Figure Lengend Snippet: Modulation of SOX2 protein stability by canonical PI3K/AKT signaling. A. Increased PI3K activity fosters SOX2 protein expression in LN319 cells. Cell were stably transfected with Doxycycline‐inducible variants of PIK3CA encoding the catalytic subunit of PI3 kinase p110. From left to right: no insert (control), PIK3CA wild type, and the constitutively active mutant alleles H1047R or E545K. Note elevated SOX2 protein expression in response to aggravated PI3K activity, as indicated by increased pAKT (Ser473) and pS6 (Ser235,236) signatures. Actin staining is shown for loading control. B. Effects of 48 h‐exposure to PI3K/AKT/TOR pathway inhibitors on SOX2 protein levels as assessed by Western blot. SOX2 expression is strongly impaired by pan PI3K‐inhibitor (BYL‐719) and AKT‐inhibitors (AKTi1/2, MK‐2206), but not by further downstream inhibitor rapamycin (anti mTORC1). C. Fluorescence microcopy to document nucleo‐cytoplasmatic displacement and reduction of SOX2 protein expression by PI3K inhibitor MK‐2206. D. Impaired invasiveness of MK‐2206‐treated, SOX2‐depleted LN319 cells as assayed by Boyden chamber experiments. E. Schematic illustration of SOX2 protein expression and turnover in dependence of PI3K/AKT signaling.
Article Snippet: SOX2 was overexpressed by addition of an
Techniques: Activity Assay, Expressing, Stable Transfection, Transfection, Mutagenesis, Staining, Western Blot, Fluorescence
Journal: Brain Pathology
Article Title: Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1
doi: 10.1111/bpa.12670
Figure Lengend Snippet: SOX2 trans‐activates 3q26 genes PIK3CA and OPA1 . A. Theoretical SOX2‐binding sequences found upstream of PIK3CA, MFN1 and OPA1 transcription initiation sites. B. ChIP of PIK3CA, MFN1 and OPA1 promoter regions containing the potential SOX2‐binding sites (LN319 cells). C. Luciferase assays of PIK3CA, MFN1 and OPA1 promoter regions containing the potential SOX2‐binding sites (HEK293 cells). Co‐transfection of SOX2 expressing vector and comparison between wild‐type and mutated sites.
Article Snippet: SOX2 was overexpressed by addition of an
Techniques: Binding Assay, Luciferase, Cotransfection, Expressing, Plasmid Preparation
Journal: Brain Pathology
Article Title: Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1
doi: 10.1111/bpa.12670
Figure Lengend Snippet: 3q26 gene products modulate glioma cell invasion in various entangled ways. SOX2 balances glioma cell invasion through intrinsically antagonistic mechanisms: While PI3K/AKT/mTOR 41 and PI3K/AKT‐SOX2 loops promote glioma invasion 9, 20, SOX2 trans‐activates OPA1, which results in an effective inhibition of invasion. OPA1 knock‐down mutations resolve this functional antagonism and lead to an effective deregulation of glioma cell invasion.
Article Snippet: SOX2 was overexpressed by addition of an
Techniques: Inhibition, Functional Assay
Journal: PLoS ONE
Article Title: Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection
doi: 10.1371/journal.pone.0045812
Figure Lengend Snippet: (A) Alkaline phosphatase (AP) staining. Seven LMF-iPS cell lines examined expressed high levels of AP, similar to D3 ES cells. (B) Immunofluorescence staining of the ES cell-specific markers Oct4 and stage-specific embryonic antigen 1 (SSEA1). Scale bars: 200 µm. (C) mRNA expression of ES cell-specific markers (Nanog, Tert, Zfp, Oct4, and Sox2) and exogenous genes (Kl4 and c-Myc). G3PDH was used as a loading control.
Article Snippet: The
Techniques: Staining, Immunofluorescence, Expressing
Journal: PLoS ONE
Article Title: Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection
doi: 10.1371/journal.pone.0045812
Figure Lengend Snippet: (A) Southern blot analysis of D3 ES cells, seven LMF-iPS cell lines, and MEF cells using probes against Oct4, Sox2, Klf4, and c-Myc. Genomic DNA (15 µg) was digested with EcoRI. The arrows indicate bands derived from the transgenes. Closed and open arrowheads indicate bands derived from endogenous genes or nonspecific bands integrated into the genomic DNA, respectively. (B) Detection of plasmid integration by PCR. Genomic DNA (100 ng) from D3 ES cells, LMF-iPS cells, and MEFs was amplified by PCR using plasmid-specific primers (amplified regions: O, Oct4; S, Sox2; K, Klf4; C, cMyc; pA, polyadenylation signal and backbone; Amp, ampicillin resistant gene; and CAG, CAG promoter). In the K and C PCR results, closed arrowheads indicate bands derived from endogenous genes and open arrowheads indicate integrated exogenous genes.
Article Snippet: The
Techniques: Southern Blot, Derivative Assay, Plasmid Preparation, Amplification
Journal: PLoS ONE
Article Title: Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection
doi: 10.1371/journal.pone.0045812
Figure Lengend Snippet: (A) Phase-contrast images of the two LMF-iPS cell lines, according to spontaneous differentiation for 20 days. (B) RT-PCR analysis of the spontaneous differentiation of the two LMF-iPS cell lines into three germ-like layers expressing undifferentiated ES cell markers (Oct4 and Nanog), as well as endodermal (α-fetoprotein and α-amylase), mesodermal (β-enolase and renin), and ectodermal (Map2 and β-tubulin) genes. (C) Immunocytochemistry of neuronal cell differentiation in the two LMF-iPS cell lines into Map2-, Tuj1-, and GFAP-positive cells. (D and E) RT-PCR and immunostaining results showing cardiac (TnI) and endothelial (Tie2) cell differentiation of two LMF-iPS cell lines. Blue nuclear staining is by DAPI.
Article Snippet: The
Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Immunocytochemistry, Cell Differentiation, Immunostaining, Staining
Journal: Journal of Biological Chemistry
Article Title: A Novel Suppressive Effect of Alcohol Dehydrogenase 5 in Neuronal Differentiation
doi: 10.1074/jbc.c114.561860
Figure Lengend Snippet: FIGURE 3. ADH5 counteracted differentiation of human neural stem cells toward neurons. A, immunostaining of the neural progenitor markers Nestin, Sox2, Pax6, and Ki67 in hNSCs. Scale bar, 50 m. B, scheme of differentiating hNSCs toward neurons. Briefly, hNSCs were transduced with lentiviral vectors (ADH5, ADH5(R115D), or empty vector) at day 0. At day 4, the transduced hNSCs subcultured in a 24-well microplate were induced to differentiation toward neurons. Immunofluorescence and qPCR were performed at day 40. C, qPCR analysis of ADH5 expression in hNSCs and their neuron derivatives. D, qPCR analysis of SOX2 and Nestin in hNSCs transduced with lentivirus expressing either EGFP (Vector) or ADH5. E, Transwell assay to analyze the relative number of migrated hNSCs transfected with lenti-EGFP or lenti-ADH5 (wt). F, immunofluorescence staining of differentiated neurons indicated in B in the absence or presenceofADH5inhibitorC3.Scalebar,50m.G,qPCRanalysisofADH5,MAP2,andGAD67,inthedifferentiatedneuronsindicatedinBandF.H,qPCRanalysis of synapsin as a marker of neuron maturation in the differentiated neurons indicated in B and F. I, qPCR analysis of glial fibrillary acidic protein (GFAP), -smooth muscle actin (SMA), and -fetoprotein (AFP) lineage-specific markers in the differentiated neurons indicated in B and F. J, scheme of differentiating hNSCs toward neurons in the presence of ADH5 inhibitor C3. Briefly, hNSCs subcultured in a 24-well microplate at day 0 were induced to differentiation toward neurons at day 3 by differentiation medium together with C3. Immunofluorescence and qPCR were performed at day 9. K, qPCR analysis of neuron-specific markers, MAP2 and GAD67, in the differentiated hNSCs treated with C3 for 6 days. All the values are shown as means S.E. n 3. Single asterisk, p 0.05; triple asterisk, p 0.001. NS, not significant.
Article Snippet: Antibodies, Plasmids, and Regents—The following antibodies were used: -actin (Santa Cruz Biotechnology), HDAC2 (Santa Cruz Biotechnology), ADH5 (
Techniques: Immunostaining, Transduction, Plasmid Preparation, Immunofluorescence, Expressing, Transwell Assay, Transfection, Staining, Marker